Media coverage
21
Media coverage
Title Positive Neoadjuvant Libtayo® (cemiplimab) Monotherapy Data in Resectable Cutaneous Squamous Cell Carcinoma Presented at ESMO and Published in NEJM – PR Newswire Media name/outlet BusinessFast.co.uk Country/Territory United Kingdom Date 12/09/22 URL ct.moreover.com/?a=48719586259&p=1gw&v=1&x=sxm58f6bHx7q0QAtV6A_gg Persons Israel Lowy, Title Positive Neoadjuvant Libtayo (cemiplimab) Monotherapy Data in Resectable Cutaneous Squamous Cell Carcinoma Presented at ESMO and Published in NEJM Media name/outlet Chase Country/Territory United States Date 12/09/22 URL ct.moreover.com/?a=48719267293&p=1gw&v=1&x=pr05hu0XjMH1-4wleTYaFg Persons Israel Lowy, Title Positive Neoadjuvant Libtayo(TM) (cemiplimab) Monotherapy Data in Resectable Cutaneous Squamous Cell Carcinoma Presented at ESMO and Published in NEJM Media name/outlet Stockwatch Country/Territory Canada Date 12/09/22 URL ct.moreover.com/?a=48719299167&p=1gw&v=1&x=tGPz9kJ2z-zp_gAf3bUSBg Persons Israel Lowy, Title Positive Neoadjuvant Libtayo® (cemiplimab) Monotherapy Data in Resectable Cutaneous Squamous Cell Carcinoma Presented at ESMO and Published... Media name/outlet Ironton Tribune Country/Territory United States Date 12/09/22 URL ct.moreover.com/?a=48719301752&p=1gw&v=1&x=19EQ8S359DMOYLrManNlCw Persons Israel Lowy, Title Positive Neoadjuvant Libtayo® (cemiplimab) Monotherapy Data in Resectable Cutaneous Squamous Cell Carcinoma Presented at ESMO and Published Media name/outlet Jessamine Journal Country/Territory United States Date 12/09/22 URL ct.moreover.com/?a=48719305690&p=1gw&v=1&x=z5-1CXeHTruFkiIDfWETzw Persons Israel Lowy, Title Positive Neoadjuvant Libtayo® (cemiplimab) Monotherapy Data in Resectable Cutaneous Squamous Cell Carcinoma Presented at ESMO and Published Media name/outlet Elizabethton.com Country/Territory United States Date 12/09/22 URL ct.moreover.com/?a=48719307795&p=1gw&v=1&x=XurnWD9haWEFNRAz7fOm-g Persons Israel Lowy, Title Positive Neoadjuvant Libtayo® (cemiplimab) Monotherapy Data in Resectable Cutaneous Squamous Cell Carcinoma Presented at ESMO and Published... Media name/outlet Davie County Enterprise Record Country/Territory United States Date 12/09/22 URL ct.moreover.com/?a=48719315426&p=1gw&v=1&x=rZiFT-A_0lRe-HlDI1FBhw Persons Israel Lowy, Title Positive Neoadjuvant Libtayo® (cemiplimab) Monotherapy Data in Resectable Cutaneous Squamous Cell Carcinoma Presented at ESMO and Published Media name/outlet Harlan Daily Enterprise Country/Territory United States Date 12/09/22 URL ct.moreover.com/?a=48719317860&p=1gw&v=1&x=4Tb_guFi2NCUCj6yBV0hbw Persons Israel Lowy, Title Positive Neoadjuvant Libtayo® (cemiplimab) Monotherapy Data in Resectable Cutaneous Squamous Cell Carcinoma Presented at ESMO and Published Media name/outlet Suffolk News Herald Country/Territory United States Date 12/09/22 URL ct.moreover.com/?a=48719318980&p=1gw&v=1&x=VjxU9ChWwEERIbrC2fkA4g Persons Israel Lowy, Title Positive Neoadjuvant Libtayo® (cemiplimab) Monotherapy Data in Resectable Cutaneous Squamous Cell Carcinoma Presented at ESMO and Published Media name/outlet Winchester Sun Country/Territory United States Date 12/09/22 URL ct.moreover.com/?a=48719329070&p=1gw&v=1&x=IzyMZlr7EmrVqPADRej76w Persons Israel Lowy, Title Positive Neoadjuvant Libtayo® (cemiplimab) Monotherapy Data in Resectable Cutaneous Squamous Cell Carcinoma Presented at ESMO and Published... Media name/outlet Coastland Times Country/Territory United States Date 12/09/22 URL ct.moreover.com/?a=48719333925&p=1gw&v=1&x=OC8eyebA957orEgJcLDvow Persons Israel Lowy, Title Positive Neoadjuvant Libtayo® (cemiplimab) Monotherapy Data in Resectable Cutaneous Squamous Cell Carcinoma Presented at ESMO and Published Media name/outlet Smithfield Times Country/Territory United States Date 12/09/22 URL ct.moreover.com/?a=48719337791&p=1gw&v=1&x=s5eKz1ugLWqXuiCdMB8AaQ Persons Israel Lowy, Title Positive Neoadjuvant Libtayo® (cemiplimab) Monotherapy Data in Resectable Cutaneous Squamous Cell Carcinoma Presented at ESMO and Published... Media name/outlet L' Observateur Country/Territory United States Date 12/09/22 URL ct.moreover.com/?a=48719342216&p=1gw&v=1&x=rnLzKb0-fHAHlA5uEpk5_A Persons Israel Lowy, Title Positive Neoadjuvant Libtayo® (cemiplimab) Monotherapy Data in Resectable Cutaneous Squamous Cell Carcinoma Presented at ESMO and Published Media name/outlet Salisbury Post Country/Territory United States Date 12/09/22 URL ct.moreover.com/?a=48719342541&p=1gw&v=1&x=kg3_AhlHjGeyLa3q-a_bJQ Persons Israel Lowy, Title Positive Neoadjuvant Libtayo® (cemiplimab) Monotherapy Data in Resectable Cutaneous Squamous Cell Carcinoma Presented at ESMO and Published... Media name/outlet Middlesboro News Country/Territory United States Date 12/09/22 URL ct.moreover.com/?a=48719342671&p=1gw&v=1&x=OYQaMvOqHKghiPgnO1LiZg Persons Israel Lowy, Title Positive Neoadjuvant Libtayo® (cemiplimab) Monotherapy Data in Resectable Cutaneous Squamous Cell Carcinoma Presented at ESMO and Published... Media name/outlet Bogalusa Daily News Country/Territory United States Date 12/09/22 URL ct.moreover.com/?a=48719348341&p=1gw&v=1&x=L0er46kzAEYnPQp_SUETjQ Persons Israel Lowy, Title Positive Neoadjuvant Libtayo® (cemiplimab) Monotherapy Data in Resectable Cutaneous Squamous Cell Carcinoma Presented at ESMO and Published... Media name/outlet Magnolia State Live Country/Territory United States Date 12/09/22 URL ct.moreover.com/?a=48719351198&p=1gw&v=1&x=8TtCZZ4TonlmhqL9bg4xRw Persons Israel Lowy, Title Positive Neoadjuvant Libtayo® (cemiplimab) Monotherapy Data in Resectable Cutaneous Squamous Cell Carcinoma Presented at ESMO and Published Media name/outlet Port Arthur News Country/Territory United States Date 12/09/22 URL ct.moreover.com/?a=48719351673&p=1gw&v=1&x=Pqe24T8Qa39D-2Mj0jMyMQ Persons Israel Lowy, Title Positive Neoadjuvant Libtayo® (cemiplimab) Monotherapy Data in Resectable Cutaneous Squamous Cell Carcinoma Presented at ESMO and Published Media name/outlet LaGrange Daily News Country/Territory Georgia Date 12/09/22 URL ct.moreover.com/?a=48719354634&p=1gw&v=1&x=JBZcJ6y_yZeloXBjoZtzPA Persons Israel Lowy, Title Positive Neoadjuvant Libtayo® (cemiplimab) Monotherapy Data in Resectable Cutaneous Squamous Cell Carcinoma Presented at ESMO and Published... Media name/outlet Alabama Now Country/Territory United States Date 12/09/22 URL ct.moreover.com/?a=48719358970&p=1gw&v=1&x=i4QLfQofsl6GlvZhNqmykw Persons Israel Lowy, Title Positive Neoadjuvant Libtayo® (cemiplimab) Monotherapy Data in Resectable Cutaneous Squamous Cell Carcinoma Presented at ESMO and Published... Media name/outlet Daily Leader.com Country/Territory United States Date 12/09/22 URL ct.moreover.com/?a=48719359012&p=1gw&v=1&x=iK6qWz--wNE81cKAtxxiwQ Persons Israel Lowy,